Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

1 Apr 2017

Abstract excerpt

Glioma is the most common and aggressive human primary tumor in the central nervous system. Despite present clinical advancements, median survival time remains poor in this malignant tumor. Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is a member of the serpin superfamily of protease inhibitors. Its aberrant expression has been observed in various tumors. However, its clinical significance and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peptidase Inhibition and Analysis
Share to Protease and Inhibitor Mechanisms
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28458560
DOI: 10.2147/ott.s133022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patientsPMID 28458560Read ↗

Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastomaSemantic proximity Read ↗

Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrenceSemantic proximity Read ↗

The Role of miRNAs in the Progression and Prognosis of GliomasSemantic proximity Read ↗

Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for GlioblastomaSemantic proximity Read ↗

Comprehensive Analysis Reveals Promising Immune Target and Prognostic Value of PLK3 in GliomaSemantic proximity Read ↗

Overview of serpin B9 and its roles in cancer (Review)Semantic proximity Read ↗

APOBEC3C Served as a Novel Immune-Related Prognosis Biomarker in Glioma: A Pan-Cancer AnalysisSemantic proximity Read ↗

Comprehensive Analysis of Expression and Prognostic Value of MS4As in GliomaSemantic proximity Read ↗

Exploration of inflammation-prognosis correlation and potential regulatory molecules in adamantinomatous craniopharyngiomaSemantic proximity Read ↗

Pan-cancer analysis reveals potential for synergy between SERPINA1 molecular targeting and macrophage-related immunotherapySemantic proximity Read ↗

Decreased expression of miR-410-3p correlates with poor prognosis and tumorigenesis in human gliomaSemantic proximity Read ↗

Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.